Correction: ¹⁸F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis

Sébastien Heyer¹, Maïa Simon², Matthieu Doyen^{1

3}, Ali Mortada¹, Véronique Roch¹, Elodie Jeanbert², Nathalie Thilly², Catherine Malaplate⁴, Anna Kearney-Schwartz^{5

6}, Thérèse Jonveaux^{6

7}, Aurélie Bannay⁸, Antoine Verger^{9

10}

Affiliations

¹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
² Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
³ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France.
⁴ Department of Biochemistry, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁵ Department of Geriatrics, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁶ CMRR, University Hospital Nancy, Nancy, F-54000, France.
⁷ Department of Neurology, University Hospital Nancy, Nancy, F-54000, France.
⁸ Medical Assessment and Information Department, Université de Lorraine, CHRU-Nancy, Nancy, 54000, France.
⁹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France. a.verger@chru-nancy.fr.
¹⁰ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France. a.verger@chru-nancy.fr.

Published Erratum

Sébastien Heyer et al. Alzheimers Res Ther. 2024.

. 2024 Nov 13;16(1):247.

doi: 10.1186/s13195-024-01608-3.

¹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
² Department of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
³ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France.
⁴ Department of Biochemistry, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁵ Department of Geriatrics, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
⁶ CMRR, University Hospital Nancy, Nancy, F-54000, France.
⁷ Department of Neurology, University Hospital Nancy, Nancy, F-54000, France.
⁸ Medical Assessment and Information Department, Université de Lorraine, CHRU-Nancy, Nancy, 54000, France.
⁹ Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France. a.verger@chru-nancy.fr.
¹⁰ Université de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France. a.verger@chru-nancy.fr.

No abstract available

Erratum for

¹⁸F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis.
Heyer S, Simon M, Doyen M, Mortada A, Roch V, Jeanbert E, Thilly N, Malaplate C, Kearney-Schwartz A, Jonveaux T, Bannay A, Verger A. Heyer S, et al. Alzheimers Res Ther. 2024 Aug 13;16(1):182. doi: 10.1186/s13195-024-01535-3. Alzheimers Res Ther. 2024. PMID: 39135067 Free PMC article.

1. Heyer S, Simon M, Doyen M, et al. 18F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis. Alz Res Therapy. 2024;16:182. 10.1186/s13195-024-01535-3. - PMC - PubMed